作者：
O'Dwyer,M.E. [1]
;
Swords,R. [2]
;
Nagler,A. [3]
;
McMullin,M.F. [4]
;
leCoutre,P.D. [5]
;
Langabeer,S.E. [6]
;
Alvarez-Iglesias,A. [7]
;
Fan,H. [8]
;
Woodman,R.C. [9]
;
Giles,F.J. ;
Conneally,E.
作者单位：
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[1]
Division of Oncology and Hematology, Charité Universit?tsmedizin Berlin, Berlin, Germany
[2]
Department of Hematology, St. James's Hospital, Dublin, Ireland
[3]
Molecular Diagnostics Laboratory, University of Texas Health Science Center San Antonio, San
[4]
HRB Clinical Research Facility, National University of Ireland, Galway, Ireland
[5]
Chaim Sheba Medical Center, Tel Hashomer, Israel
[6]
Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States
[7]
Center for Cancer Research and Cell Biology, Queens University, Belfast, Northern Ireland, United
[8]
Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer
[9]
发布时间
2014-06-29
换一批
换一批
